Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.05.22.655574

MACHINE LEARNING FOR MISSING DATA IMPUTATION IN ALZHEIMER'S RESEARCH: PREDICTING MEDIAL TEMPORAL LOBE FLEXIBILITY

Abstract

BACKGROUNDAlzheimers disease (AD) begins years before symptoms appear, making early detection essential. The medial temporal lobe (MTL) is one of the earliest regions affected, and its network flexibility, a dynamic measure of brain connectivity, may serve as a sensitive biomarker of early decline. Cognitive (acquisition, generalization), genetic (APOE, ABCA7), and biochemical (P-tau217) markers may predict MTL dynamic flexibility. Given the high rate of missing data in AD research, this study uses machine learning with advanced imputation methods to predict MTL dynamic flexibility from multimodal predictors in an aging cohort. METHODSIn an ongoing study at Rutgerss Aging and Brain Health Alliance, data from 656 participants are utilized, including cognitive assessments, genetic and blood-derived biomarkers, and demographics. Due to MRI-related constraints, only 34.15% of participants had measurable MTL dynamic flexibility from resting-state fMRI. To estimate MTL dynamic flexibility from available data, we evaluated four missing data handling methods (case deletion, MICE, MissForest, and GAIN), and trained five regression models: Ridge, k-NN, SVR, regression trees (bagging, random forest, boosting), and ANN. Hyperparameters were optimized via grid search with 3-fold cross-validation. Model performance was assessed using mean absolute error (MAE), root mean squared error (RMSE), and runtime through 5-fold cross-validation repeated 25 times to ensure robustness in clinical data settings. RESULTSA total of 1,866 missing values (25.86%) were identified in the dataset, with only 42 complete cases (6.40%) remaining after listwise deletion, highlighting the need for effective imputation. In the initial analysis using only complete cases, support vector regression (SVR) achieved the lowest mean absolute error (MAE = 0.184), though overall performance was limited due to small sample size. In the second phase, three imputation techniques were applied, significantly improving model accuracy. MissForest combined with Random Forest produced the best results (MAE = 0.083), representing a 54.7% improvement over case deletion. Statistical analysis confirmed significant differences in performance across imputation methods (p < 0.001), with MissForest outperforming GAIN and MICE. GAIN was the fastest imputation method. DISCUSSIONThe findings underscore the importance of using robust imputation strategies to maximize data utility and model reliability in studies with high missingness. Further research is needed, particularly incorporating additional neuroimaging measures, to localize the brain regions most affected by biomarker-driven changes and to refine predictive models for clinical applications.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Moallemian, S., Saghafi, A., Deshpande, R., Perez, J. M., Budak, M., Fausto, B. A., Elahi, F., Gluck, M. A.. 2025-05-27. MACHINE LEARNING FOR MISSING DATA IMPUTATION IN ALZHEIMER'S RESEARCH: PREDICTING MEDIAL TEMPORAL LOBE FLEXIBILITY. https://doi.org/10.1101/2025.05.22.655574

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗